Endothelin Receptor

Endothelin Receptor

Items: 1–10 of

Show:

50

20

50

100

Cat. No.	Product Name	CAS No.	Information
CSN13675	Zibotentan	186497-07-4	Zibotentan is an orally administered potent and specific ETA-receptor endothelin A receptor antagonist IC50 21 nM
CSN12014	Sulfisoxazole	127-69-5	Sulfisoxazole is an antagonist of endothelin receptor that can be used as a sulfonamide antibacterial agent
CSN11008	Sodium Ferulate	24276-84-4	Sodium ferulate is the sodium salt of ferulic acid which is used for the treatment of cardiovascular disease
CSN12974	Sitaxsentan Sodium	210421-74-2	Sitaxsentan sodium has selectory antagonism of endothelin A ETA receptor with the IC50 and Ki value of 14 nM and 043 nM respectively
CSN12975	Sitaxsentan	184036-34-8	Sitaxsentan is a selective endothelin A (ETA) receptor antagonist.
CSN17902	Ro 46-2005	150725-87-4	Ro 46-2005 is an antagonist of endothelin receptor
CSN18333	Macitentan N-Butyl Analogue	556797-16-1	Macitentan n-butyl analogue is a n-butyl analogue of Macitentan ACT064992 which is an orally active non-peptide dual endothelin ETA and ETB receptor antagonist for the potential treatment of idiopathic pulmonary fibrosis IPF and pulmonary arterial hypertension PAH
CSN13736	Macitentan	441798-33-0	Macitentan is an antagonist of endothelin receptor A ETA with IC50 of 05 nM It is developed for treatment of pulmonary arterial hypertension PAH
CSN22138	J-104132	198279-45-7	J-104132 is a potent, orally active ETAETB receptor antagonist, with Kis of 0.034 nM and 0.104 nM for cloned human ETA and ETB receptors expressed in CHO cells.
CSN20320	HJP272	1072467-37-8	HJP272, an endothelin receptor antagonist, attenuates lipopolysaccharide-induced acute lung injury.
CSN23533	Darusentan	171714-84-4	Darusentan is an antagonist of endothelin ETA receptor and it can be used to treat congestive heart failure and hypertension
CSN19760	Clazosentan	180384-56-9	Clazosentan is a potent endothelin A antagonist, improves cerebral blood flow and behavior after traumatic brain injury.
CSN17348	BQ-788 Sodium	156161-89-6	BQ-788 sodium salt is a potent selective ETB receptor antagonist with IC50 of 12 nM for inhibition of ET-1 binding to human Girardi heart cells poorly inhibiting the binding to ETA receptors in human neuroblastoma cell line SK-N-MC cells with IC50 of 1300 nM
CSN18010	BQ-788	173326-37-9	BQ-788 is a potent and selective endothelin receptor subtype B ETB antagonist with IC50 of 12 nM inhibits 125I-labeled endothelin 1 ET-1 binding to ETB receptors on human Girardi heart cells
CSN17753	BQ-123	136553-81-6	BQ-123 is a specific antagonist of endothelin A receptor ETA and the IC50 is 73 nM
CSN10481	Bosentan Hydrate	157212-55-0	Bosentan is an endothelin (ET) receptor antagonist of ET-A (Ki 4.7 nM) and ET-B (Ki 95 nM).
CSN10480	Bosentan	147536-97-8	Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.
CSN12872	Avosentan	290815-26-8	Avosentan is a potent, selective endothelin receptor (ETA receptor) antagonist.
CSN18015	Atrasentan	173937-91-2	Atrasentan is an endothelin receptor antagonist (IC500.0551 nM, ETA) being developed for the treatment of prostate cancer.
CSN13753	Atrasentan HCl	195733-43-8	Atrasentan HCl is an endothelin receptor antagonist (IC50=0.0551 nM, ETA) being developed for the treatment of prostate cancer.
CSN10496	Ambrisentan	177036-94-1	Ambrisentan is an oral, once-daily endothelin receptor antagonist that is selective for the endothelin type A receptor (IC50s 0.251, 0.316, 0.398, 251, and 630 nM for rat preparations of heart, bladder, kidney, lung, and cerebral cortex, respectively).
CSN17466	ACT-132577	1103522-45-7	ACT-132577 is the major and pharmacologically active metabolite of macitentan which is dual ETAETB endothelin ET receptor antagonist designed for tissue targeting

<< PREV 1 NEXT >>

Endothelin Receptor Items: 1–10 of Show: 50 20 50 100

50

Endothelin Receptor

Items: 1–10 of

Show:

50

20

50

100